)
Shares of Aarti Drugs has dipped 14% at Rs 575 on the National Stock Exchange (NSE) in early morning today after the pharmaceutical company gets US FDA (Food and Drug Administration) import alert on its manufacturing plant in Tarapur, Maharashtra.
Meanwhile, the stock turned ex-bonus in the ratio of 1:1 i.e. 1 (one) bonus equity share of Rs 10 each fully paid up for every 1 (one) existing equity share of Rs 10 each fully paid up held in the company.
In past two months, the stock had rallied 24% compared with 3.7% fall in the CNX Nifty after the company announced bonus issue.
The stock opened at Rs 624 and touched a low of Rs 559 on the NSE. A combined 241,130 shares changed hands on the counter on the NSE and BSE so far.
At 0948 hours, the stock was down 12% at Rs 593 on the NSE.
Meanwhile, the stock turned ex-bonus in the ratio of 1:1 i.e. 1 (one) bonus equity share of Rs 10 each fully paid up for every 1 (one) existing equity share of Rs 10 each fully paid up held in the company.
In past two months, the stock had rallied 24% compared with 3.7% fall in the CNX Nifty after the company announced bonus issue.
The stock opened at Rs 624 and touched a low of Rs 559 on the NSE. A combined 241,130 shares changed hands on the counter on the NSE and BSE so far.
At 0948 hours, the stock was down 12% at Rs 593 on the NSE.
